U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07266285) titled 'A Phase 1 Trial of BTM-3566 in Advanced Solid Tumors' on Nov. 18.
Brief Summary: The goal of this clinical trial is to learn about what doses of BTM-356 are safe to use in adults with advanced cancers in solid tumors. It will also learn about how effective different doses of BTM-3566 are in treating cancer. The main questions it aims to answer are:
What adverse events and toxicities (harmful side effects) are associated with different doses of BTM-3566? What are the blood levels of BTM-3566 in your body at different timepoints? What effect does BTM-3566 have on reducing tumor size and/or preventing the worsening of cancer? All parti...